Evidence map›Paper›PMID 40966222›Full record

ArticlePloS one2025

E-cigarette or vaping product use-associated lung injury outbreak and public perceptions and trends in smoking cessation discussions on Twitter.

Yuqi Zhang, Yingning Wang

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yuqi ZhangCenter for Data Science, New York University, New York, New York, United States of America.ORCID https://orcid.org/0000-0003-0716-6436
Yingning WangInstitute for Health & Aging, School of Nursing, University of California, San Francisco, San Francisco, California, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCigarette smokers often use e-cigarettes to quit smoking. The outbreak of e-cigarette, or vaping, product use-associated lung injury (EVALI) in 2019 summer sparked discussions about vaping. However, there is a gap in exploring EVALI's impact on discussions related to smoking cessation and vaping in smoking cessation on social media.

objectiveThis study examines trends, sentiments, and topics in smoking cessation discussions before, during, and after EVALI.

methodsEnglish tweets from September 1, 2018, to January 31, 2020, were collected using snscrape, filtered for smoking-cessation-related keywords. Sentiments were assessed with Valence Aware Dictionary and sEentiment Reasoner (VADER), categorizing tweets as positive, negative, or neutral. Topics were identified via Latent Semantic Analysis, and LexRank was used to extract representative sentences for qualitative insights into the discussions.

resultsAmong 397,528 smoking cessation-related tweets, discussions significantly increased in September 2019, accompanied by a decline in sentiment scores. Five topic groups-"Vaping", "Cannabis", "Stop Smoking", "Gum", and "Tobacco"-were identified. "Vaping" dominated the entire timespan, surpassing other topics in volume. Sentiment scores decreased for "Vaping", "Stop Smoking", and "Cannabis" in September 2019, while remaining stable for "Gum" and "Tobacco". Representative sentences showed that despite the EVALI outbreak, many individuals still perceived vaping as an effective smoking cessation tool and oppose tobacco control policies targeting e-cigarette flavors.

conclusionsThe results deepen our comprehension of how perceptions regarding smoking cessation evolve during EVALI, offering insights for refining public health communication strategies in future health crises.

Indexed as

Electronic Nicotine Delivery SystemsLung InjurySmoking CessationSocial MediaVapingDisease OutbreaksHumans

Identifiers

PMID40966222
PMCPMC12445456

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.